May 20th 2021
Expanded coverage under a Medicare-Medicaid partnership to treat all prevalent cases of hepatitis C appears to be cost-effective by saving money and improving patient outcomes.
February 15th 2020
Segment 4 - Considering the Costs of Hepatitis C Treatment
February 18th 2014While some patients and physicians are not aware of the costs of care, others are concerned about whether they can afford treatment options at all. Dr Miller describes some of the major steps to the incremental benefits and incremental costs incurred by new agents.
Read More
Segment 3 - Engaging Patients in Discussions About Treating Hepatitis C
February 18th 2014Despite the relatively inexpensive 1-time tests to screen for hepatitis C virus (HCV), Dr Fendrick and the panel explore the concerns that plan sponsors may have regarding the costs of new specialty drugs made to treat HCV.
Read More
Segment 2 - The Effects of Health Reform on Treatment of Hepatitis C
February 18th 2014In this clip, the panel discusses the implications of health reform on the treatment of hepatitis C virus (HCV), including what is needed to improve outcomes. This includes educating primary care physicians about how the Affordable Care Act requires health plans to pay for the costs of testing and screening for risk factors of HCV.
Read More
Segment 1 - Hepatitis C in the Healthcare Reform Era
February 18th 2014Dr Mark Fendrick, University of Michigan, co-editor-in-chief, AJMC, moderates a discussion with Dr David Winston, section head of gastroenterology & hepatology, Cigna HealthCare of Arizona; Dr Steven Miller, chief medical officer, Express Scripts; and Dr Nezam H. Afdhal, associate professor of medicine, Harvard School of Medicine, chief of hepatology, director of Liver Center, Beth Israel Deaconess Medical Center.
Read More
Evaluation of Human Immunodeficiency Virus and Hepatitis C Telemedicine Clinics
In an integrated health system, human immunodeficiency virus and hepatitis C telemedicine clinics are associated with improved access, high patient satisfaction, and reduction in health visit“related time.
Read More
Absenteeism and Productivity Among Employees Being Treated for Hepatitis C
Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.
Read More